The persistent overexpression of NMYC in quiescent, self-renewing stem cells suggests a role for this gene in maintaining stem cell-like properties (e.g., self-renewal, chemoresistance, etc.), suggesting its potential as a determinant of high-grade neuroblastoma [4]. This evidence concerns the gene MYCN and neuroblastoma.